REMSleep Holdings, Inc. Annual Report: Key Highlights and Investor Update

Executive Summary

REMSleep Holdings, Inc. (“REMSleep” or “the Company”) has released its latest annual report, providing critical insights into its financial health, business strategy, and operational outlook. This update is particularly important for shareholders and potential investors, given several items that may significantly impact share value.

Key Financial Highlights

• Net Loss Substantially Increased: For the year ended December 31, 2025, REMSleep reported a net loss of \$3,020,300, a major increase compared to the net loss of \$1,077,997 in 2024. This deepening loss is attributed to ongoing operational expenses, limited revenues, and costs related to financing and product development.
• Accumulated Deficit: The Company’s accumulated deficit reached \$18,291,056 as of December 31, 2025, raising substantial doubts about its ability to continue as a going concern without additional financing.
• Share Dilution: During Q4 2025, a major debt conversion resulted in the issuance of 50,586,353 shares of common stock, following the conversion of \$63,700 in principal and \$3,635 in interest. This significantly increases the outstanding share count and could impact share price due to dilution.
• Funding and Liquidity: In 2025, REMSleep raised \$254,000 from convertible notes. The prior year saw \$225,000 raised (with \$93,000 repaid) and \$420,000 from common stock sales. No cash was used or received for investing activities in 2025, while \$124,700 was used in 2024 for equipment and tooling.
• Stockholder’s Equity: The Company’s stockholder equity remains low, with a balance of \$32,062 as of December 31, 2025, down from \$336,703 in 2024—reflecting ongoing losses and limited capital raises.
• Common Stock Details: The common stock has a \$0.001 par value and is listed on the OTC Markets Group under the symbol “RMSL.” As of April 10, 2026, there were approximately 157 shareholders of record.

Going Concern Warning

Substantial Doubt Over Future Operations: Both the Company and its independent auditors have highlighted substantial doubt about REMSleep’s ability to continue as a going concern. The Company’s continued operations rely heavily on the ability to secure additional financing. Failure to obtain such financing may result in the need to liquidate assets or seek bankruptcy protection.

This warning is critical and highly price-sensitive. Investors should be aware that the Company’s survival is not guaranteed without new capital infusions.

Business Operations & Outlook

• Product and Market Focus: REMSleep targets the sleep apnea market, aiming to commercialize products like “DeltaWave” through agreements with hospital distributors, internet retailers, and direct marketing campaigns. The business plan includes building brand awareness via multimedia advertising, SEO, and targeted press releases.
• Manufacturing: The Company currently uses molds made in China but is considering relocating manufacturing to the United States.
• Operations Contingent on Financing: All aspects of the Company’s business plan—manufacturing, marketing, sales, and product development—are entirely dependent on raising adequate funds. Failure to raise capital will negatively impact the Company’s financial condition and could result in bankruptcy.
• Employees: The Company operates with only two employees (CEO Jeffrey Marshall and COO Anita Michaels). All other roles are filled by independent contractors and additional personnel will only be added as funds permit.

Risks and Uncertainties

• Financing Risk: The Company’s future is tied to its ability to secure financing. Without new funds, operations cannot continue.
• Shareholder Dilution Risk: Recent and potential future issuances of common stock, particularly via conversion of debt, will likely lead to ongoing dilution for existing shareholders.
• No Environmental Regulation Exposure: The Company is not subject to environmental regulation.
• Legal Proceedings: There are no material legal claims or investigations pending against the Company or its officers.
• Critical Accounting Estimates: The Company’s critical accounting policies include the valuation of financial instruments, revenue recognition, and allowance for doubtful accounts. These involve management’s significant judgment and are subject to change.

Auditor’s Report

• Unqualified Opinion with Going Concern Emphasis: The independent registered public accounting firm issued an unqualified opinion on the financial statements but emphasized the substantial doubt regarding the Company’s ability to continue as a going concern.
• Critical Audit Matters: Revenue recognition was identified as a critical audit matter, given the significant judgment required to determine satisfaction of performance obligations and proper timing of revenue recognition.

Shareholder Actions and Price Sensitive Issues

• Potential Share Price Impact: The ongoing net losses, heavy reliance on external financing, and recurring share dilutions are highly material and may exert significant downward pressure on the Company’s share price.
• Bankruptcy Risk: If the Company fails to raise additional capital, it may be forced to liquidate or seek bankruptcy protection, which could result in a total loss for shareholders.
• Uncertain Revenue Path: Despite efforts in marketing and distribution, the Company has yet to demonstrate sustainable revenue generation, which is a key risk factor for investors.

Conclusion

REMSleep Holdings, Inc. faces significant financial and operational challenges. While the Company is actively seeking to commercialize its products and establish market presence, its ability to continue as a going concern is uncertain. Shareholders should closely monitor developments regarding financing and operational execution, as these will determine the Company’s viability and future share performance.

Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Investors are encouraged to conduct their own analysis and consult with professional advisors before making investment decisions. The information provided is based on the latest available public filings and may not reflect subsequent events or changes.

View RemSleep Holdings Inc. Historical chart here